Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Shukra Pharmaceuticals Ltd Partly Paidup
Shukra Pharmaceuticals Ltd Partly Paidup

Shukra Pharmaceuticals Ltd Partly Paidup Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 0
Jul 06, 2023
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹103.75
₹-5.45 (-%)
103.75Low
Today’s Performance
103.75High
0.00Low
52 Week’s Performance
103.75High

bt_logoStock Performance

  • No records found!!!

bt_logoStock Summary

  • Face Value (₹)6.00
  • Beta-
  • 52-Week Low (₹)-
  • 52-Week High (₹)-
  • Price-to-Book (X)*17.29
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*-
  • Earnings Per Share (₹)-
  • Market Cap (₹ Cr.)*0.13
* Values as of last close price

bt_logoCOMPETITORS

BT TV

"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
Vikram Misri: India–Russia to Accelerate FTA, Investment Treaty and Key Connectivity Negotiations1:58Vikram Misri: India–Russia To Accelerate FTA, Investment Treaty And Key Connectivity Negotiations
‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War3:01‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War
View more

bt_logoFAQ's

What was Shukra Pharmaceuticals Ltd Partly Paidup share price previously?
Shukra Pharmaceuticals Ltd Partly Paidup share price was down by -% from the previous closing price of ₹-.
Who are peers of Shukra Pharmaceuticals Ltd Partly Paidup?
The peers of Shukra Pharmaceuticals Ltd Partly Paidup are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd, Mankind Pharma Ltd, Aurobindo Pharma Ltd, Alkem Laboratories Ltd.
Who is/are the promoter/promoters of Shukra Pharmaceuticals Ltd Partly Paidup?
The promotor/promotors of Shukra Pharmaceuticals Ltd Partly Paidup are
What has been 52-week high of Shukra Pharmaceuticals Ltd Partly Paidup stocks?
The highest price of Shukra Pharmaceuticals Ltd Partly Paidup stock is ₹- in the last 52-week.
What is the share price of Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP) today on BSE?
As on Jul 06, 2023 Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP)’s share price on BSE is Rs 103.75
What is the market cap of Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP)?
The current market capitalisation of Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP) is 0.13 crores
What is Shukra Pharmaceuticals Ltd Partly Paidup Share symbol?
The symbol of Shukra Pharmaceuticals Ltd Partly Paidup is .
What is the PE ratio of Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP)?
The current PE ratio of Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP) is -.
What is the PB ratio of Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP)?
The current PB ratio of Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP) is 17.29.
Today’s High & Low share prices of Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP) on BSE?
Today, the share price of Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP) on BSE touched a high of Rs 103.75 and a low of Rs 103.75
What price did Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP) shares open on the BSE today?
On BSE, the share price of Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP) opened at Rs 103.75
What is the 52-week high of Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP)?
The 52-week high price of Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP) is Rs 103.75
What is the 52-week low of Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP)?
The 52-week low price of Shukra Pharmaceuticals Ltd Partly Paidup (SHUKRAPP) is Rs 0.00

bt_logoAbout Shukra Pharm. PP

Shukra Pharmaceuticals Ltd Partly Paidup, incorporated in the year 1993, has its registered office in Ahmedabad, Gujarat, 380054. The main industry in which Shukra Pharmaceuticals Ltd Partly Paidup operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Shukra Pharmaceuticals Ltd Partly Paidup is/are . In the main management, is chairman and is the company secretary for Shukra Pharmaceuticals Ltd Partly Paidup.

    bt_logoTop Stories

    DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

    DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

    By using this website, you agree to the Terms of Service and Privacy Policy.